Basic Information
| LncRNA/CircRNA Name | circCDYL |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Mantle Cell Lymphoma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | Mantle Cell Lymphoma plasma and cell lines |
| Expression Pattern | up-regulated |
| Function Description | CircCDYL was high expressed in the plasma of MCL patients. Functionally, circCDYL knockdown inhibited MCL cell proliferation. |
| Pubmed ID | 31819653 |
| Year | 2019 |
| Title | CircCDYL Serves as a New Biomarker in Mantle Cell Lymphoma and Promotes Cell Proliferation |
External Links
| Links for circCDYL | GenBank HGNC NONCODE |
| Links for Mantle Cell Lymphoma | OMIM COSMIC |